- Home
- LII vs ILMN Comparison
LII vs ILMN Comparison
Compare LII & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LII
- ILMN
- Stock Information
- Founded
- LII 1895
- ILMN 1998
- Country
- LII United States
- ILMN United States
- Employees
- LII N/A
- ILMN N/A
- Industry
- LII Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- LII Industrials
- ILMN Health Care
- Exchange
- LII Nasdaq
- ILMN Nasdaq
- Market Cap
- LII 17.4B
- ILMN 18.4B
- IPO Year
- LII 1999
- ILMN 2000
- Fundamental
- Price
- LII $472.09
- ILMN $121.34
- Analyst Decision
- LII Hold
- ILMN Hold
- Analyst Count
- LII 12
- ILMN 15
- Target Price
- LII $607.00
- ILMN $114.93
- AVG Volume (30 Days)
- LII 560.6K
- ILMN 2.0M
- Earning Date
- LII 10-22-2025
- ILMN 10-30-2025
- Dividend Yield
- LII 1.10%
- ILMN N/A
- EPS Growth
- LII 12.46
- ILMN N/A
- EPS
- LII 23.67
- ILMN 4.46
- Revenue
- LII $5,345,300,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- LII N/A
- ILMN N/A
- Revenue Next Year
- LII $7.61
- ILMN $2.22
- P/E Ratio
- LII $19.92
- ILMN $27.05
- Revenue Growth
- LII 3.77
- ILMN N/A
- 52 Week Low
- LII $466.88
- ILMN $68.70
- 52 Week High
- LII $689.44
- ILMN $153.06
- Technical
- Relative Strength Index (RSI)
- LII 31.77
- ILMN 64.31
- Support Level
- LII $466.88
- ILMN $118.50
- Resistance Level
- LII $498.78
- ILMN $125.50
- Average True Range (ATR)
- LII 15.22
- ILMN 5.35
- MACD
- LII -0.80
- ILMN 0.77
- Stochastic Oscillator
- LII 9.12
- ILMN 84.19
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.